#reservoir

This finding adds yet another degree of complexity to the byzantine puzzle that is the search for a cure for the virus.

An amfAR grant goes to two University of Massachusetts scientists exploring a novel technique.

Researchers have found that in addition to CD4s, macrophage cells can harbor HIV even in the face of antiretroviral treatment.

Researchers may have answered a bedeviling chicken-or-egg question about the persistence of HIV during antiretroviral treatment.

Pharmaceutical giant Gilead Sciences has awarded over $22 million in grants for 12 HIV-cure-focused research projects.

Funding will support these 12 research- and community-based projects.

In a 111-person group of people treated for HIV, the average viral reservoir half-life was 12 years.

Campbell Foundation funds nontraditional avenues of research.

Yet another study has shown the extreme complexity of the viral reservoir, where HIV hides from ARV treatment, frustrating cure attempts.

Even when people with HIV have an undetectable viral load, the virus replicates in lymph nodes, which helps replenish the viral reservoir.

A manufactured, two-headed protein has succeeded in awakening latently HIV-infected immune cells, summoning an immune response to kill them.

Bristol-Myers Squibb has announced the 2015 recipients of its Partnering for Cure research grants.

In addition to possibly being a part of the HIV reservoir, fat tissue may be a source of harmful chronic inflammation among those with HIV.

Cutting through the hype and hyperbole.

The reactivation rate of cells latently infected with HIV is much lower than previously thought.

The National Institutes of Health's Division of AIDS and Infectious Disease Services has pledged $6.6 million to support the first human clini...